Clinical Trial Update: Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a treatment for symptomatic peripheral neuropathy in diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Chromaderm, Inc. | Conditions: Diabetic Neuropathies, Diabetes Mellitus, Insulin-Dependent | Phase 3 | Status: COMPLETED